Security Snapshot

CytomX Therapeutics, Inc. - COMMON STOCK (CTMX) Institutional Ownership

CUSIP: 23284F105

13F Institutional Holders and Ownership History from Q4 2015 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

141

Shares (Excl. Options)

141.97MFull value: 141,971,527 · shares · 30 Sep 2026

Price

$2.72

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-5,383,800
Value change
-$22,146,064
Number of holders
141
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
220,142,805
SEC-reported price per share
$2.31
Insider filing price
$2.31
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CTMX - CytomX Therapeutics, Inc. - COMMON STOCK is tracked under CUSIP 23284F105.
  • 141 institutions reported positions in Q3 2026.
  • 12 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 178 to 141 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $798.99MFull value: $798,992,521 · USD · 30 Jun 2026
    to
    $386.17MFull value: $386,165,430 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 141 institutions filings for Q3 2026.

Open SEC evidence

Security key

23284F105

13F reference period

Q3 2026

13F holders

141

13D/G owners

12

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
12
Security
CTMX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +18% $105,171,344 +$17,756,285 24,688,109 +20% FMR LLC 31 Dec 2025
BlackRock, Inc. 7.6% $62,067,945 16,551,452 BlackRock, Inc. 30 Jun 2026
Longitude Capital Partners V, LLC 7% -4.3% $65,740,382 +$16,125,000 15,288,461 +33% Patrick G. Enright 31 Mar 2026
BANK OF AMERICA CORP /DE/ 5.4% -23% $32,278,273 -$8,888,081 11,867,012 -22% BANK OF AMERICA CORP /DE/ 30 Sep 2026
PERCEPTIVE ADVISORS LLC 4.6% -22% $43,424,943 +$1,800,148 10,098,824 +4.3% Perceptive Advisors LLC 31 Mar 2026
Venrock Healthcare Capital Partners III, L.P. 4.6% -53% $42,923,133 -$23,991,317 9,982,124 -36% Venrock Healthcare Capital Partners III, L.P. 31 Mar 2026
STATE STREET CORP 4.1% -26% $24,550,326 -$7,402,156 9,025,855 -23% STATE STREET CORPORATION 30 Sep 2026
Point72 Asset Management, L.P. 3.6% -28% $28,900,822 -$11,298,128 7,811,033 -28% Point72 Asset Management, L.P. 30 Jun 2026
BIOTECHNOLOGY VALUE FUND L P 3.5% -47% $17,250,001 -$17,250,001 5,769,231 -50% BVF PARTNERS L P/IL 03 Jul 2025
ORBIMED ADVISORS LLC 2.1% -66% $15,160,295 -$21,224,155 3,525,650 -58% OrbiMed Advisors LLC 31 Dec 2025
Seven Fleet Capital Management LP 0.5% $4,667,211 +$4,456,950 1,085,398 +2120% Seven Fleet Master Fund LP 31 Mar 2026
Seven Fleet Partners LP 0.2% $267,784 377,161 Seven Fleet Partners LP 13 May 2025
As of 30 Sep 2026, 141 institutional investors reported holding
141.97MFull value: 141,971,527 · shares · 30 Sep 2026
shares of CytomX Therapeutics, Inc. - COMMON STOCK (CTMX). This represents 64% of the company’s total
220.14MFull value: 220,142,805 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Kynam Capital Management, LP 9.6% 21,140,726 3.2% $57,502,775
BANK OF AMERICA CORP /DE/ 5.3% 11,567,870 0% $31,464,606
PERCEPTIVE ADVISORS LLC 4.2% 9,268,061 0.47% $25,209,126
STATE STREET CORP 4.1% 9,025,855 0% $24,550,326
VANGUARD CAPITAL MANAGEMENT LLC 4% 8,732,337 0% $23,751,957
Point72 Asset Management, L.P. 3.9% 8,604,802 0.04% $23,405,061
TWO SIGMA INVESTMENTS, LP 2.4% 5,384,720 0.01% $14,646,438
GEODE CAPITAL MANAGEMENT, LLC 2.3% 5,093,451 0% $13,856,441
BAKER BROS. ADVISORS LP 2.3% 4,975,826 0.06% $13,534,247
WELLINGTON MANAGEMENT GROUP LLP 2.1% 4,731,685 0% $12,870,183
Elmind Capital, LP 2.1% 4,550,000 3.1% $12,376,000
Nextech Invest Ltd. 2% 4,449,932 0.54% $12,103,815
MARSHALL WACE, LLP 2% 4,362,687 0.01% $11,866,508
Qube Research & Technologies Ltd 1.9% 4,187,989 0.01% $11,391,330
Eversept Partners, LP 1.6% 3,544,163 0.56% $9,640,123
Siren, L.L.C. 1.6% 3,457,711 0.22% $9,404,974
GOLDMAN SACHS GROUP INC 1.5% 3,196,615 0% $8,694,793
Woodline Partners LP 0.94% 2,062,469 0.02% $5,609,916
VANGUARD PORTFOLIO MANAGEMENT LLC 0.93% 2,056,401 0% $5,593,411
VANGUARD FIDUCIARY TRUST CO 0.63% 1,393,595 0% $3,790,578
683 Capital Management, LLC 0.6% 1,319,900 0.34% $3,590,128
Assenagon Asset Management S.A. 0.54% 1,181,259 0% $3,213,024
Seven Fleet Capital Management LP 0.49% 1,085,398 0.58% $2,952,283
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.47% 1,043,451 0% $2,838,187
Jump Financial, LLC 0.34% 737,868 0.02% $2,007,001

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
44
Headline period
Q3 2026
Rows shown
1-25 of 44
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 141,971,527 $386,165,430 -$22,146,064 $2.72 141
2026 Q2 213,036,700 $798,992,521 +$65,019,587 $3.75 178
2026 Q1 193,169,653 $907,862,078 +$226,598,991 $4.70 179
2025 Q4 144,051,943 $613,664,738 +$47,313,431 $4.26 122
2025 Q3 137,411,371 $438,342,190 +$24,527,196 $3.19 102
2025 Q2 133,305,109 $302,602,132 +$213,797,054 $2.27 82
2025 Q1 45,180,958 $28,723,084 -$1,507,772 $0.64 63
2024 Q4 46,714,805 $48,111,898 -$6,381,441 $1.03 68
2024 Q3 51,193,741 $60,427,306 +$480,690 $1.18 69
2024 Q2 50,687,257 $61,863,474 +$334,609 $1.22 73
2024 Q1 44,548,308 $97,118,414 +$26,024,246 $2.18 85
2023 Q4 32,640,376 $50,592,909 +$410,206 $1.55 66
2023 Q3 32,393,313 $41,785,804 -$2,418,556 $1.29 61
2023 Q2 34,120,916 $58,688,106 -$2,378,087 $1.72 66
2023 Q1 35,594,054 $53,751,153 -$933,381 $1.51 74
2022 Q4 35,979,014 $120,192,376 -$724,794 $1.60 77
2022 Q3 36,281,610 $52,604,898 -$18,986,577 $1.45 76
2022 Q2 45,579,430 $83,410,352 -$17,825,825 $1.83 86
2022 Q1 53,661,262 $143,355,949 -$1,754,233 $2.67 112
2021 Q4 54,342,875 $235,299,521 -$5,313,006 $4.33 106
2021 Q3 53,978,233 $274,775,521 -$17,338,127 $5.09 111
2021 Q2 56,688,576 $358,879,555 +$4,313,452 $6.33 119
2021 Q1 54,613,642 $422,156,729 +$130,257,296 $7.73 123
2020 Q4 37,995,365 $248,881,255 +$5,576,359 $6.55 123
2020 Q3 36,841,081 $245,069,950 -$11,639,890 $6.65 128
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .